Host's response in otitis media: Understanding genetic susceptibility

Pediatric Infectious Disease Journal

Volumn 27, Issue 10, 2008, Pages 929-933

  Ilia, Stavroula ^a   Goulielmos, George N ^a   Samonis, George ^a   Galanakis, Emmanouil ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Genetic susceptibility; Host's response; Immunogenetics; Otitis media; Polymorphisms

Indexed keywords

CYTOKINE; FC RECEPTOR; GAMMA INTERFERON; HLA A2 ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 4; INTERLEUKIN 5; MANNOSE BINDING LECTIN; MUCIN; SURFACTANT PROTEIN A; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; FBXO11 GENE; GENE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; INNATE IMMUNITY; JEFF GENE; MOUSE; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIAE; TYMPANOSTOMY TUBE; CHILD; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY;

CHILD; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OTITIS MEDIA;

EID: 54049148693     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318174e0b0     Document Type: Review

References (72)

1. Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM. Otitis media. Lancet. 2004;363:465-473.
2. Goldstein NA, Casselbrant ML, Bluestone CD, Kurs-Lasky M. Intratemporal complications of acute otitis media in infants and children. Otolaryngol Head Neck Surg. 1998;119:444-454.
3. Bluestone CD. Pathogenesis of otitis media: role of eustachian tube. Pediatr Infect Dis J. 1996;15:281-291.
4. Goodwin JH, Post JC. The genetics of otitis media. Curr Allergy Asthma Rep. 2002;2:304-308.
5. Post JC. Direct evidence of bacterial biofilms in otitis media. Laryngoscope. 2001;111:2083-2094.
6. Uhari M, Mäntysaari K, Niemelä M. A meta-analytic review of the risk factors for acute otitis media. Clin Infect Dis. 1996;22:1079-1083.
7. Stenstrom C, Ingvarsson L. Otitis prone children and controls: a study of possible predisposing factors. 2. Physical findings, frequency of illness, allergy, day care and parental smoking. Acta Otolaryngol. 1997;117: 696-703.
8. Casselbrant ML, Mandel EM. Genetic susceptibility to otitis media. Curr Opin Allergy Clin Immunol. 2005;5:1-4.
9. Ruskamp JM, Hoekstra MO, Rovers MM, Schilder AG, Sanders EA. Mannose-binding lectin and upper respiratory tract infections in children and adolescents: a review. Arch Otolaryngol Head Neck Surg. 2006; 132:482-486.
10. Casselbrant ML, Mandel EM, Fall PA, et al. The heritability of otitis media: a twin and triplet study. JAMA. 1999;282:2125-2130.
11. Casselbrant ML, Mandel EM, Rockette HE, et al. The genetic component of middle ear disease in the first 5 years of life. Arch Otolaryngol Head Neck Surg. 2004;130:273-278.
12. Kvaerner KJ, Tambs K, Harris JR, Magnus P. Distribution and heritability of recurrent ear infections. Ann Otol Rhinol Laryngol. 1997;106: 624-632.
13. Rovers M, Haggard M, Gannon M, Koeppen-Schomerus G, Plomin R. Heritability of symptom domains in otitis media: a longitudinal study of 1,373 twin pairs. Am J Epidemiol. 2002;155:958-964.
14. Daly KA, Rich SS, Levine S, et al. The family study of otitis media: design and disease and risk factors profiles. Genet Epidemiol. 1996;13: 451-468.
15. Rasmussen F. Protracted secretory otitis media: the impact of familial factors and day-care center attendance. Int J Pediatr Otorhinolaryngol. 1993;26:29-37.
16. Daly KA, Casselbrant ML, Hoffman HJ, et al. Recent advances in otitis media. 2. Epidemiology, natural history and risk factors. Ann Otol Rhinol Laryngol Suppl. 2002;188:19-25.
17. Kalm O, Johnson U, Prellner K, Ninn K. HLA frequency in patients with recurrent acute otitis media. Arch Otolaryngol Head Neck Surg. 1991; 117:1296-1299.
18. Kalm O, Johnson U, Prellner K. HLA frequency in patients with chronic secretory otitis media. Int J Pediatr Otorhinolaryngol. 1994; 30:151-157.
19. Mortenson EH, Lildholt T, Gammelgard NP, Christensen PH. Distribution of ABO blood groups in secretory otitis media and cho-lesteatoma. Clin Otolaryngol. 1983;8:263-265.
20. Rockley TJ, Rhys Evans PH. Secretory otitis media-evidence for an inherited aetiology. J Laryngol Otol. 1986;100:389 -393.
21. Harsten G, Prellner K, Heldrup J, Kalm O, Kornfalt R. Recurrent acute otitis media. A prospective study of children during their first three years of life. Acta Otolaryngol. 1989;107:111-119.
22. Klein JO. Epidemiology of otitis media. Pediatr Infect Dis J. 1989; 8(suppl):S9.
23. Klein JO. Hereditary and environmental factors in otitis media. Ann Otol Rhinol Laryngol Suppl. 1990;99:S46-S47.
24. Hardisty RE, Erven A, Logan K, et al. The deaf mouse mutant Jeff(Jf) is a single gene model of otitis media. J Assoc Res Otolaryngol. 2003;4:130-138.
25. Segade F, Daly KA, Allred D, et al. Association of the FBXO11 gene with chronic otitis media with effusion and recurrent otitis media. Arch Otolaryngol Head Neck Surg. 2006;132:729-733.
26. Daly KA, Brown WM, Segade F, et al. Chronic and recurrent otitis media: a genome scan for susceptibility loci. Am J Hum Genet. 2004; 75:988-997.
27. Kerschner JE. Mucin gene expression in human middle ear epithelium. Laryngoscope. 2007;117:1666-1676.
28. Smirnova MG, Birchall JP, Pearson JP. TNF-a in the regulation of MUC5AC secretion: some aspects of cytokine-induced mucin hyperse- cretion on the in vitro model. Cytokine. 2000;12:1732-1736.
29. Elsheikh MN, Mahfouz ME. Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up- regulation of MUC5B in middle ear in pediatric otitis media with effusion. Laryngoscope. 2006;116:365-369.
30. Lin J, Haruta A, Kawano H, et al. Induction of mucin gene expression in middle ear of rats by TNF-a: potential cause for mucoid otitis media. J Infect Dis. 2000;182:882-887.
31. Kerschner JE, Burrows A, Meyer TK. Chinchilla middle ear epithelial mucin gene expression in response to inflammatory cytokines. Arch Otolaryngol Head Neck Surg. 2004;130:1163-1167.
32. Schroder NW, Schumann RR. Single nucleotide polymorphisms of toll-like receptors and susceptibility to infectious diseases. Lancet Infect Dis. 2005;5:156-164.
33. Szezepanski M, Szyfter W, Jenek R, et al. Toll-like receptors 2,3 and 4 (TLR-2, TLR-3 and TLR-4) are expressed in the microenvironment of human acquired cholesteatoma. Eur Arch Otorhinolaryngol. 2006;263: 603-607.
34. Lorenz E, Hallman M, Marttila R, Haataja R, Schwartz DA. Association between the Asp299Gly polymorphism in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res. 2002;52:373-376.
35. Tal G, Mandelberg A, Dalal I, et al. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis. 2004;189:2057-2063.
36. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun. 2000;68:6398 -6401.
37. Kang TJ, Lee SB, Chae GT. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine. 2002;20:56-62.
38. Eder W, Klimecki W, Yu L, et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol. 2004;113:482-488.
39. Emonts M, Veenhoven RH, Wiertsema SP, et al. Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics. 2007;120: 814-823.
40. Thiel S, Frederiksen PD, Jensenius JC. Clinical manifestations of mannan- binding lectin deficiency. Mol Immunol. 2006;43:86-89.
41. Thórarinsdóttir HK, Lúdviksson BR, Víkíngsdóttir T, et al. Childhood levels of immunoglobulins and mannan-binding lectin in relation to infections and allergy. Scand J Immunol. 2005;61:466-474.
42. Koch A, Melbye M, Sorensen P, et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA. 2001;285:1316-1321.
43. Sraetemans M, Wiertsema SP, Sanders EA, et al. Immunological status in the aetiology of recurrent otitis media with effusion: serum immunoglobulin levels, functional mannose-binding lectin and Fc receptor polymorphisms for IgG. J Clin Immunol. 2005;25:78-86.
44. Nuytinck L, De Meester E, Van Thielen M, Govaerts P. Role of mannose-binding lectin (MBL2) genotyping in predicting the risk of recurrent otitis media (ROM). Adv Exp Med Biol. 2006;586:281-290.
45. Wiertsema SP, Herpers BL, Veenhoven RH, et al. Functional polymorphisms in the mannan-binding lectin 2 gene: effect on MBL levels and otitis media. J Allergy Clin Immunol. 2006;117:1344-1350.
46. Homoe P, Madsen HO, Sandvej K, Koch A, Garred P. Lack of association between mannose-binding lectin, acute otitis media and early Ebstein-Barr virus infection among children in Greenland. Scand JInfect Dis. 1999;31:363-366.
47. McGuire JF. Surfactant in the middle ear and eustachian tube: a review. Inter J Pediatr Otorhinolaryngol. 2002;66:1-15.
48. Lim DJ, Chun YM, Lee HY, et al. Cell biology of tubotympanum in relation to pathogenesis of otitis media-a review. Vaccine. 2001;19: 17-25.
49. Ramet M, Lofgren J, Alho OP, Hallman M. Surfactant protein-A gene locus associated with recurrent otitis media. J Pediatr. 2001; 138:266-268.
50. Pettigrew MM, Gent JF, Zhu Y, et al. Association of surfactant protein A polymorphisms with otitis media in infants at risk for asthma. BMC Med Genet. 2006;7:68.
51. Chen A, Li HS, Hebda PA, Zeevi A, Swarts JD. Gene expression profiles of early pneumococcal otitis media in the rat. Int J Pediatr Otorhinolaryngol. 2005;69:1383-1393.
52. Gentile DA, Doyle WJ, Zeevi A, et al. Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection. Hum Immunol. 2003;64:338-344.
53. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax. 2000;55:1023-1027.
54. Das S, Palmer OP, Leight WD, et al. Cytokine amplification by respiratory syncytial virus infection in human nasal epithelial cells. Laryngoscope. 2005;115:764-768.
55. Patel JA, Nair S, Revai K, et al. Association of proinflammatory cytokine gene polymorphisms with susceptibility to otitis media. Pediatrics. 2006;118:2273-2279.
56. Joki-Erkkilä VP, Puhakka H, Hurme M. Cytokine gene polymorphism in recurrent acute otitis media. Arch Otolaryngol Head Neck Surg. 2002; 128:17-20.
57. Sobol SE, Taha R, Schloss MD, et al. T(H)2 cytokine expression in atopic children with otitis media with effusion. J Allergy Clin Immunol. 2002;110:125-130.
58. Smirnova MG, Birchall JP, Pearson JP. Evidence of T-helper cell 2 cytokine regulation of chronic otitis media with effusion. Acta Otolaryngol. 2005;125:1043-1050.
59. Melhus A, Ryan AF. Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat. Infect Immun. 2000;68:4024-4031.
60. Van der Pol W, Van de Winkel JG. IgG receptor polymorphisms: risk factors for disease. Immunogenetics. 1998;48:222-232.
61. Karassa FB, Trikalinos TA, Ioannidis JP. The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases. Biomed Pharmacother. 2004;58:286-291.
62. Freijd A, Hammarstrom L, Persson MA, Smith CI. Plasma anti-pneu- mococcal antibody activity of the IgG class and subclasses in otitis prone children. Clin Exp Immunol. 1984;56:233-238.
63. Wiertsema SP, Veenhoven RH, Walraven V, et al. Pneumococcal vaccine efficacy for mucosal pneumococcal infections depends on Fcγ receptor IIa polymorphism. Vaccine. 2006;24:792-797.
64. Prellner K, Hallberg T, Kalm O, Mansson B. Recurrent otitis media: genetic immunoglobulin markers in children and their parents. Int J Pediatr Otorhinolaryngol. 1985;9:219-225.
65. Li W, Lin J, Adams GL, Juhn SK. Expression of inducible nitric oxide synthase (iNOS) in middle ear epithelial cells by IL-1beta and TNF- alpha. Int J Pediatr Otorhinolaryngol. 2000;55:91-98.
66. Moon SK, Woo JI, Lee HY, et al. Toll-like receptor 2-dependent NF-kappaB activation is involved in nontypeable Haemophilus influenzae-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear. Infect Immun. 2007;75:3361-3372.
67. Melhus A, Ryan AF. Expression of molecular markers for bone formation increases during experimental acute otitis media. Microb Pathog. 2001;30:111-120.
68. Rosser TL, Acosta MT, Packer RJ. Aicardi syndrome: spectrum of disease and long-term prognosis in 77 females. Pediatr Neurol. 2002; 27:343-346.
69. Barrenas M, Landin-Wilhelmsen K, Hanson C. Ear and hearing in relation to genotype and growth in Turner syndrome. Hear Res. 2000; 144:21-28.
70. Löfgren J, Rämet M, Renko M, Marttila R, Hallman M. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis. 2002;185:283-289.
71. Lahti M, Lofgren J, Marttila R, et al. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res. 2002;51:696-699.
72. Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med. 1999;340:260-264.